1ST Biotherapeutics
Latest round
- Series D
Last raised
- Jan 2026
Total raised
- $60M
Investors
- 21
About 1ST Biotherapeutics
Founded in 2016, 1ST Biotherapeutics, Inc. specializes in the development of therapeutics addressing critical medical needs. In January 2026, 1ST Biotherapeutics, Inc.1ST Biotherapeutics specializes in the discovery and development of therapeutics aimed at addressing critical unmet medical needs in neurodegenerative diseases, immuno-oncology, and rare diseases. Their portfolio includes drug candidates that leverage advances in genomic-based target discovery and biomarker identification, with a focus on improving patient treatment outcomes.60 for the same year.
Who invested in 1ST Biotherapeutics
21 investors across 4 rounds
See all investors in 1ST Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 1ST Biotherapeutics
Who invested in 1ST Biotherapeutics?
1ST Biotherapeutics has 21 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 1ST Biotherapeutics raised?
1ST Biotherapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did 1ST Biotherapeutics last raise money?
1ST Biotherapeutics's most recent round on record is a Series D, in Jan 2026.
What does 1ST Biotherapeutics do?
Founded in 2016, 1ST Biotherapeutics, Inc.
Where is 1ST Biotherapeutics headquartered?
1ST Biotherapeutics is headquartered in Yongin, South Korea.
Which VCs invest in companies like 1ST Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at 1ST Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like 1ST Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.